ClinicalTrials.gov
ClinicalTrials.gov Menu

Permanent Observatory of Heart Failure (ODIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01091441
Recruitment Status : Completed
First Posted : March 24, 2010
Last Update Posted : November 24, 2017
Sponsor:
Information provided by (Responsible Party):
Juilliere, French Cardiology Society

Brief Summary:

The observatory consists of a row of data collection on a population composed of all patients with heart failure cared for in centers participating in the national education program for patients (named I-CARE) in the form of two groups. Patients who are undergoing a program of therapeutic education track are listed and included in the group of patients educated. Patients who receive no education or only a minimal element for any reason whatsoever are also listed and included in the group of patients who are not educated.

The following of patients will be periodic after their entry in the observatory, up to 2 years of follow up.


Condition or disease
Acute Heart Failure

Detailed Description:

The Center for patients with heart failure cared for in a center practicing therapeutic education dedicated to heart failure.

The definition of heart failure selected for inclusion is that recommended by the European Society of Cardiology : presence of at least two signs or symptoms of heart failure (dyspnea, edema of the ankles crackles) at rest or during exercise associated with objective evidence (preferably by echocardiography) of cardiac dysfunction ( systolic and / or diastolic) (resting) and in case of doubt, a response to specific treatment of heart failure.

All patients who are undergoing a program of therapeutic education track are listed and included in the group of patients educated.

All patients who receive no education or only a minimal element for any reason whatsoever are also listed and included in the group of patients who are not educated.

Follow up is done by CRAs at the French Society of Cardiology, by mailing and phone contacts.


Study Type : Observational
Actual Enrollment : 3248 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Permanent Observatory of Heart Failure
Study Start Date : February 2007
Actual Primary Completion Date : July 2014
Actual Study Completion Date : July 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Group/Cohort
Patients with heart failure
Patients hospitalized for acute heart failure



Primary Outcome Measures :
  1. Event-free survival [ Time Frame: 2 years ]
    To analyse survival after 2 years of follow-up (all-causes death)


Secondary Outcome Measures :
  1. Recurrence of heart failure [ Time Frame: 2 years ]
    Analyze the data of disease: recurrence of heart failure

  2. Therapeutic [ Time Frame: 2 years ]
    Analyze the data of disease: therapeutic took 2 years of follow-up

  3. Number of participants with adverse events [ Time Frame: 2 years ]
    Analyze the data of disease: cardiovascular events or other non-cardiovascular



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All patients with heart failure in France

The definition of heart failure selected for inclusion is that recommended by the European Society of Cardiology (The Task Force for the Diagnosis and Treatment of Congestive Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115 -- 1140): presence of at least two signs or symptoms of heart failure (dyspnea, edema of the ankles crackles) at rest or during exercise associated with objective evidence (preferably by echocardiography) of cardiac dysfunction ( systolic and / or diastolic) (resting) and in case of doubt, a response to specific treatment of heart failure

Criteria

Inclusion Criteria:

  • Patient with heart failure
  • Patient supported by a center participating in the I-CARE french program

Exclusion Criteria:

  • Refusal by the patient to be listed in an observatory

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01091441


Locations
France
Brabois-Nancy University Hospital
Vandoeuvre les Nancy, France, 54500
Sponsors and Collaborators
French Cardiology Society

Publications of Results:
Responsible Party: Juilliere, Professor, French Cardiology Society
ClinicalTrials.gov Identifier: NCT01091441     History of Changes
Other Study ID Numbers: 06302
First Posted: March 24, 2010    Key Record Dates
Last Update Posted: November 24, 2017
Last Verified: November 2017

Keywords provided by Juilliere, French Cardiology Society:
therapeutic education

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases